Lung cancer is still the leading cause of cancer-related death worldwide in both genders with more than 2 million new cases and 1.8 million deaths in 2020.
Unlike histopathological methods, OSNA (one-step nucleic acid amplification) enables a fast, molecular whole-node analysis. It provides nodal staging and prognosis accuracy as well as an improved basis for personalised fully-informed treatment decisi